Skip to main content
Erschienen in: BMC Cardiovascular Disorders 1/2016

Open Access 01.12.2016 | Research article

Association between novel arterial stiffness indices and risk factors of cardiovascular disease

verfasst von: Masaki Okamoto, Fumiaki Nakamura, Terunaga Musha, Yasuki Kobayashi

Erschienen in: BMC Cardiovascular Disorders | Ausgabe 1/2016

Abstract

Background

Prevention and early detection of arterial stiffness are required to avoid severe cardiovascular events. Recently, new noninvasive arterial stiffness indices, the arterial pressure volume index (API) and the arterial velocity pulse index (AVI), have been developed. The purpose of this study was to examine the clinical validity of these new indices by investigating the association between known risk factors of cardiovascular disease (CVD) and API or AVI in a large population.

Methods

This cross-sectional survey included 7248 adults who underwent an annual medical checkup at a single medical institution. API and AVI were measured using cuff oscillometry by trained nurses. We used correlation coefficients, t-tests, and multiple regression analyses to evaluate associations, and calculated intraclass correlation coefficients (ICC) to examine test-retest reliabilities of these indices.

Results

Mean age was 45.5 years (SD = 5.8), and 4083 (56.3 %) participants were men, while 3165 were women. Mean values of API and AVI were 25.1 (SD = 7.0) and 16.6 (SD = 5.4), respectively. API was strongly correlated with body mass index (BMI), systolic blood pressure (sBP), and diastolic blood pressure (dBP) (r > 0.3, p < 0.001). AVI was strongly correlated with age, sBP, and API (r > 0.3, p < 0.001). Multiple regression analyses showed that sex, age, BMI, and sBP were independently associated with API. Sex, age, BMI, sBP, fasting plasma glucose (FPG), and smoking condition were also independently associated with AVI. As reliabilities of measurements, the ICC of API was 0.74, and the ICC of AVI was 0.80.

Conclusions

These new noninvasive arterial stiffness indices, which had high test-retest reliabilities, were associated with known risk factors of CVD. Further study is warranted to determine the clinical validity of these indices.
Abkürzungen
ABI
ankle brachial pressure index
API
arterial pressure volume index
AVI
arterial velocity pulse index
BMI
body mass index
CAVI
cardio ankle vascular index
CVD
cardiovascular disease
dBP
diastolic blood pressure
FPG
fasting plasma glucose
ICC
intraclass correlation coefficient
IMT
intima-media thickness
PWV
pulse wave velocity
sBP
systolic blood pressure

Background

Arterial stiffness is independently associated with an increased risk of cardiovascular disease (CVD) [1, 2]. Several studies have shown that pulse wave velocity (PWV), a noninvasive clinical index of arterial stiffness, predicts cardiovascular events and all-cause mortality [38]. Prevention and early detection of arterial stiffness need to be promoted to avoid severe cardiovascular events. Existing methods of assessing arterial stiffness or atherosclerosis such as PWV, Cardio Ankle Vascular Index (CAVI), or carotid artery intima-media thickness (IMT) are technically difficult for medical staff unfamiliar with such measurements. Moreover, these instruments are uncomfortable for patients, because of long measurement times and postural requirements. Simpler and easier methods that can be used in daily clinical settings are required. Recently, new novel arterial stiffness indices have been developed, including the arterial pressure volume index (API), and the arterial velocity pulse index (AVI). API and AVI are measured oscillometrically at one-side of the upper arm, and in a sitting position similar to conventional measurements of blood pressure.
While technical theories support the utility of API and AVI as arterial stiffness indices [9, 10], the clinical significance of the indices has not been fully investigated, especially in the general healthy population. Thus, the aim of this study was to examine the clinical validity of the new indices by investigating associations between known risk factors for CVD and API or AVI, and also to examine test-retest reliabilities of the indices in a large healthy population.

Methods

Study participants

We conducted a cross-sectional survey of 7248 healthy adults (4083 males and 3165 females) who were aged 20 and over, and who underwent an annual medical checkup at a single large medical institution in Hachinohe, Aomori prefecture, Japan, between April 2014 and March 2015. The purpose and procedure of the study were explained to participants, who then provided written informed consent to be included.
The study protocol was approved by the Ethics Committee at Hachinohe West Health Medical Plaza and the Ethics Committee at The University of Tokyo Graduate School of Medicine (approval number: 10588).

API and AVI

Using the time series of occlusive cuff pressure and amplitudes of pulse oscillations, local slopes of the curve between decreasing cuff pressure and corresponding arterial pressure volume were calculated [9]. A complete pressure-volume curve was derived from numerical integration of the local slopes. The curve was fitted using an equation: F(x) = A arctan(Bx + C) + D (A,C,D; constant),and API was defined as a numerical coefficient B of the equation, which could evaluate arterial stiffness as it closely reflected the slope of the curve. AVI has the characteristic of pulse waves at higher cuff pressures compared with systolic BP, and central BP is simultaneously reflected in pulse waves [1012]. The systolic latter oscillometric waveform was increased by the enhancement of reflected wave, which was influenced by aging and peripheral arterial resistance, and then it steeply descended. On the other hand, the incident waveform was not influenced by reflected wave. Therefore, a ratio of these amplitude of differentiated waveform was defined as AVI, which indicated the reflected wave magnitude. Increased AVI indicated enhancement of reflected waves, which was considered to be influenced by aging or advanced arteriosclerosis.
The indices were measured using cuff oscillometry with PASESA AVE-1500 (Shisei Datum, Tokyo, Japan) by trained nurses. A cuff was wrapped around one-side of the upper arm of seated participants after they had an adequate resting period. One minute was needed for measurements conducted during the series of medical checkups for study participants.

Reliability of measurements

Participants included for the first two months (n = 1085) were measured twice within an interval of 5 min to examine the reliability of measurements.

Other variables

Individual results of medical checkup for study participants were also collected with their consent. Information about age, sex, former diagnosis of major diseases, medication history, family history of hypertension, smoking condition, alcohol consumption, and exercise habits was obtained using a self-administered questionnaire. Height, weight, abdominal circumference, blood pressure, and heart rate were measured by nurses. Blood tests, including hemoglobin, total protein, albumin, eGFR, fasting plasma glucose (FPG), and cholesterol were also conducted for each participant.

Other arterial stiffness or atherosclerosis indices

IMT, CAVI, and Ankle Brachial pressure Index (ABI) were also conducted in some of the participants (IMT, n = 513; CAVI and ABI, n = 121). These participants voluntarily requested these tests related to arterial stiffness or atherosclerosis.

Statistical analysis

We calculated correlation coefficients between API or AVI and for continuous variables. We used t-tests to compare differences in mean API or AVI according to dichotomous variables. Regarding reliabilities of measurements, we calculated intraclass correlation coefficients (ICC) of API and AVI among those who were measured twice in the first two months (n = 1085). Finally, multiple regression analysis was performed to investigate the association between API or AVI and other variables, using a backward stepwise elimination. A p value of < 0.05 was considered statistically significant. All analyses were performed using Stata/MP ver. 13.1 (StataCorp, TX, USA).

Results

Table 1 shows baseline characteristics of the study participants. Mean age was 45.5 years (SD = 5.8), and 4083 (56.3 %) participants were men, while 3165 were women. With regard to average values of body mass index (BMI), BP, and blood tests, participants did not exhibit a skewed distribution to the normal range. The proportion of participants who had family history of hypertension was 30.9 %, whereas 9.2 % of participants were diagnosed with hypertension. Overall, 2531 (34.9 %) participants were current smokers. Mean API was 25.1 (SD = 7.0), and mean AVI was 16.6 (SD = 5.4). The distributions of API and AVI are shown in Fig. 1. For reliabilities of measurements, the ICC of API was 0.74, and the ICC of AVI was 0.80.
Table 1
Baseline characteristics of participants
No. of subjects
7248
 
Sex
  
  Male
4083
[56.3]
  Female
3165
[43.7]
Age (years)
45.5 ± 5.8
 
Height (cm)
165.1 ± 8.5
 
BMI (kg/m2)
23.8 ± 4.1
 
Abdominal circumference (cm)
82.7 ± 10.5
 
sBP (mmHg)
120.5 ± 15.8
 
dBP (mmHg)
77.5 ± 10.7
 
HR (/min)
66.1 ± 9.4
 
Hemoglobin (g/dL)
14.5 ± 1.8
 
Total protein (g/dL)
7.1 ± 0.4
 
Albumin (g/dL)
4.4 ± 0.2
 
eGFR (%)
76.6 ± 12.5
 
AST (IU/L)
21.8 ± 12.3
 
ALT (IU/L)
24.9 ± 20.0
 
FPG (mg/dL)
103.0 ± 20.6
 
HbA1c (NGSP, %)
5.5 ± 0.7
 
Total cholesterol (mg/dL)
203.2 ± 34.2
 
LDL cholesterol (mg/dL)
125.1 ± 33.6
 
HDL cholesterol (mg/dL)
65.4 ± 17.8
 
Triglyceride (mg/dL)
117.3 ± 108.6
 
Hypertension
668
[9.2]
Diabetes mellitus
286
[3.9]
Dyslipidemia
393
[5.4]
Medications
  
  Antihypertension
634
[8.7]
  Antidiabetes
219
[3.0]
  Lipid-lowering
346
[4.7]
Family history of hypertension
2242
[30.9]
Current smoker
2531
[34.9]
API
25.1 ± 7.0
 
AVI
16.6 ± 5.4
 
Data are means ± SD or n [%]. Abbreviations: BMI body mass index, sBP systolic blood pressure, dBP diastolic BP, HR heart rate, eGFR estimated glomerular filtration rate, AST aspartate aminotransferase, ALT alanine aminotransferase, FPG fasting plasma glucose, HbA1c hemoglobin A1c, LDL low density lipoprotein, HDL high density lipoprotein, SD standard deviation
Table 2 shows correlation coefficients between API or AVI and continuous variables. Both API and AVI were associated with several variables. Particularly, API was strongly correlated with BMI, sBP, and dBP (r > 0.3, p < 0.001). AVI was strongly correlated with age, sBP, and API (r > 0.3, p < 0.001). Scatter plots of API and AVI by age, BMI, and sBP are shown in Fig. 2.
Table 2
Coefficients of correlation between API or AVI and other variables
Variables
Male
Female
All participants
 
API
AVI
API
AVI
API
AVI
API
 
0.232✳✳
 
0.383✳✳
 
0.316✳✳
Age (years)
0.143✳✳
0.450✳✳
0.244✳✳
0.355✳✳
0.180✳✳
0.387✳✳
Height (cm)
-0.057✳✳
-0.161✳✳
-0.106✳✳
-0.188✳✳
-0.080✳✳
-0.220✳✳
BMI (kg/m2)
0.303✳✳
-0.072✳✳
0.363✳✳
-0.013
0.318✳✳
-0.071✳✳
Abdominal circumference (cm)
0.281✳✳
-0.045✳
0.334✳✳
-0.004
0.285✳✳
-0.061✳✳
sBP (mmHg)
0.516✳✳
0.315✳✳
0.538✳✳
0.415✳✳
0.493✳✳
0.306✳✳
dBP (mmHg)
0.371✳✳
0.265✳✳
0.381✳✳
0.371✳✳
0.346✳✳
0.257✳✳
HR (/min)
0.152✳✳
0.129✳✳
0.136✳✳
0.025
0.144✳✳
0.087✳✳
Hemoglobin (g/dL)
0.081✳✳
-0.051✳
0.015
0.009
0.002
-0.122✳✳
Total protein (g/dL)
0.129✳✳
-0.066✳
0.060
0.009
0.091✳✳
-0.043
Albumin (g/dL)
0.073✳
-0.188✳✳
0.009
0.011
0.033
-0.129✳✳
eGFR (%)
-0.034
-0.035
0.065✳
0.055✳
0.018
0.020
AST (IU/L)
0.097✳✳
0.029
0.106✳✳
0.060✳
0.080✳✳
-0.001
ALT (IU/L)
0.136✳✳
-0.054✳
0.141✳✳
0.025
0.106✳✳
-0.076✳✳
FPG (mg/dL)
0.150✳✳
0.190✳✳
0.213✳✳
0.120✳✳
0.147✳✳
0.112✳✳
HbA1c (NGSP, %)
0.141✳✳
0.172✳✳
0.202✳✳
0.147✳✳
0.154✳✳
0.142✳✳
Total cholesterol (mg/dL)
0.046✳
-0.016
0.086✳✳
0.086✳✳
0.058✳✳
0.010
LDL cholesterol (mg/dL)
0.040✳
-0.053✳✳
0.114✳✳
0.043✳
0.067✳✳
-0.036✳
HDL cholesterol (mg/dL)
-0.034✳
0.051✳
-0.121✳✳
0.024
-0.061✳✳
0.085✳✳
Triglyceride (mg/dL)
0.079✳✳
0.033
0.193✳✳
0.125✳✳
0.082✳✳
0.007
✳✳p < 0.001
p < 0.05
Table 3 shows differences in API or AVI by dichotomous variables, using t-tests. Mean API and AVI in women were higher compared with men. Mean API and AVI in those with hypertension, dyslipidemia, diabetes, or family history of hypertension were higher compared with those without. Mean AVI in everyday drinkers was also higher, but not API.
Table 3
Differences in API or AVI by dichotomous variables, using t-tests
 
Mean API (± SD)
P value
Mean AVI
P value
 
+
-
 
+
-
 
Male
24.8 ± 6.1
25.3 ± 8.0
0.0035
15.9 ± 4.9
17.5 ± 5.9
<0.001
Hypertension
27.5 ± 7.0
24.6 ± 6.8
<0.001
18.5 ± 6.4
16.2 ± 5.1
<0.001
Dyslipidemia
26.8 ± 6.8
24.7 ± 6.9
<0.001
17.5 ± 6.0
16.4 ± 5.2
<0.001
Diabetes
27.3 ± 6.5
24.8 ± 6.9
<0.001
18.6 ± 6.1
16.3 ± 5.2
<0.001
Family history of hypertension
25.6 ± 7.2
24.8 ± 6.8
<0.001
16.9 ± 5.5
16.5 ± 5.4
0.0044
Current smoker
24.4 ± 6.3
25.1 ± 7.2
<0.001
16.3 ± 5.0
16.5 ± 5.4
0.0779
Everyday drinking
24.9 ± 6.4
24.8 ± 7.0
0.5629
16.8 ± 5.4
16.3 ± 5.2
<0.001
Exercise habit
25.0 ± 6.7
24.8 ± 6.9
0.5691
16.3 ± 5.2
16.5 ± 5.3
0.2939
Table 4 shows the results of multiple regression analysis of API or AVI using the backward stepwise method. Sex, age, BMI, and sBP, were independently associated with API. Sex, age, BMI, sBP, FPG, and smoking condition were also independently associated with AVI.
Table 4
Multiple regression analysis of API or AVI (backward stepwise)
 
API
AVI
 
coef.
95 % CI
P value
p.c.
coef.
95 % CI
P value
p.c.
Male
-2.921
-3.218, -2.623
<0.001
-0.215
-2.752
-3.001, -2.504
<0.001
-0.262
Age
0.074
0.047, 0.102
<0.001
0.068
0.296
0.274, 0.318
<0.001
0.318
BMI
0.313
0.275, 0.351
<0.001
0.194
-0.233
-0.265, -0.202
<0.001
-0.180
sBP
0.206
0.196, 0.216
<0.001
0.444
0.119
0.111, 0.127
<0.001
0.344
FPG
 
Removing
  
0.015
0.008, 0.021
<0.001
0.058
LDL-c
 
Removing
  
-0.003
-0.007, 0.000
0.067
-0.023
Smoker
 
Removing
  
0.807
0.569, 1.045
<0.001
0.083
adjusted R-square = 0.297
adjusted R-square = 0.267
Abbreviations: coef. coefficient, p.c. partial correlation
Finally, Table 5 shows correlation coefficients between API or AVI and previous arterial stiffness or atherosclerosis indices. Except for CAVI-API, statistically significant associations were found for all indices.
Table 5
Correlation coefficients between API or AVI and IMT, ABI, CAVI
 
API
 
AVI
 
 
r
P value
r
P value
IMT
0.116
<0.01
0.210
<0.01
ABI
-0.229
<0.01
-0.259
<0.01
CAVI
0.144
0.115
0.200
<0.05
Abbreviations: IMT intima-media thickness, ABI ankle brachial pressure index, CAVI cardio ankle vascular index

Discussion

In this study, we found significant associations between API or AVI and known risk factors for CVD, which might support the clinical validity of these new arterial stiffness indices. In addition, the test-retest reliabilities of API and AVI were acceptably high. This is the first study to assess associations between known risk factors for CVD and API or AVI in a large healthy population. Typical risk factors such as sex, age, BMI, and sBP were independently associated with API as determinants. Similarly, AVI was independently associated with sex, age, BMI, sBP, FPG, and smoking condition. This suggests that the indices could be useful total vascular risk markers.
Regarding test-retest reliability of the measurements, the ICCs of API (0.74) and AVI (0.80) were acceptably high, because the indices were affected by enduring hemodynamic changes, even after a 5-minute interval.
API and AVI were associated with typical risk factors for arterial stiffness such as age, sex, blood pressure, diseases (hypertension, dyslipidemia, diabetes), and family history of hypertension. Other arterial stiffness indices such as PWV or CAVI evaluate vascular condition, especially reduction in arterial compliance along the long axis of arteries, by attaching two or more cuffs. IMT assesses structural changes in arteries. API and AVI evaluate arterial compliance similarly; however, these indices focus the pulse wave component, extracted with a cuff attached, at only one place. This study showed that API significantly correlated with IMT and CAVI. In addition, AVI significantly correlated with IMT, ABI, and CAVI. Despite differences in technical theory of the measurements, the findings above support the validity of API and AVI as vascular risk markers.
Although, in univariate analysis, mean API and AVI in current smokers were lower compared with non-smokers, this relationship disappeared in multiple regression analysis. Confounders such as sex or age might affect this association. Furthermore, items related to API or AVI were different between the indices. This might indicate differences in vascular sites evaluated based on the background technical theory. Specifically, API mainly reflects stiffness of the peripheral arteries, whereas AVI reflects stiffness of the central arteries [9, 10]. Compared with API, AVI includes pulse wave reflected central blood pressure as a component. Indeed, some studies showed that AVI was an independent predictor of central blood pressure in patients with cardiovascular disease [11, 12]. We found that moderate or strong correlations between API and BMI, sBP, dBP, and between AVI and age, sBP, dBP existed while that modest but statistically significant correlations existed between these arterial stiffness indices and other factors. We can say that both of API and AVI are obviously BP-dependent indices as this study showed. However, BPs were not directly included as part of calculation as mentioned above, and therefore, the association was due to factors related arterial stiffness but not mathematical reasons. The same applied for BMI and age. These observations deserve further investigation.
Some limitations of the present study must be acknowledged. First, self-report measurements are generally less accurate; therefore, past history or family history of diseases might be biased. However, the prevalences of family history of each disease were consistent with available Japanese data (13). Second, participants in the current study were not necessarily representative of the general Japanese population. Participants in this study were individuals who had a medical checkup of their own volition at a large-scale medical facility. While a large number of community residents visit the facility, study participants were not chosen at random. However, this population comprised people mainly in their 40s, with the prevalence of cardiovascular risk factors similar to available Japanese data [13]. Third, other unmeasured factors such as socioeconomic factors may have affected our findings. Social structure and educational background in the catchment area of the current study is somewhat different from typical urban areas, because the number of residents engaged in primary industry is about 1.6 times the average in Japan [14]. Fourth, we could not compare new arterial stiffness indices with traditional and standard ones such as carotid-femoral PWV because of the study design. Finally, the cross-sectional nature of this study limited our ability to discuss causality.
In the future, a longitudinal study to determine the extent of the effect that measuring API and AVI has on the development of cardiovascular diseases, and all-cause mortality, should be conducted. Because API and AVI are measured non-invasively in a short time (about 1 minute), similar to conventional measurement of blood pressure, the indices could allow people easy access to vascular condition information, not only in medical checkups, but also in daily life settings, without any need for medical technicians. This study suggests that API and AVI might have clinical significance as arterial stiffness measures. Thus, further research into API and AVI in terms of arterial stiffness prevention is warranted.

Conclusion

These new noninvasive arterial stiffness indices, which had high test-retest reliabilities, were associated with known risk factors for CVD. Further study is warranted to determine the clinical validity of these indices.

Acknowledgements

None.

Funding

No funding was obtained for this study.

Availability of data and materials

Data stored in Hachinohe West Health Medical Plaza cannot be truly anonymized due to the large number of potentially identifiable items of information regarding each participant, and therefore the data cannot be shared under the research and ethical guideline in Japan. If any person wishes to verify our data, they are most welcome to contact the corresponding author.

Authors’ contributions

MO participated in design of the study, data collection, statistical analysis, and drafted the manuscript. FN participated in study design, statistical analysis, and drafting of the manuscript. TM participated in data collection and drafting of the manuscript. YK participated in study design, statistical analysis, revision for key intellectual content, and drafting of the manuscript. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.
Not applicable.
The purpose and procedure of the study were explained to participants, who then provided written informed consent to be included. The study protocol was approved by the Ethics Committee at Hachinohe West Health Medical Plaza, and the Ethics Committee at The University of Tokyo Graduate School of Medicine (approval number: 10588).
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
1.
Zurück zum Zitat Oliver JJ, Webb DJ. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol. 2003;1(23):554–66.CrossRef Oliver JJ, Webb DJ. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol. 2003;1(23):554–66.CrossRef
2.
Zurück zum Zitat Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, Asmar R, Reneman RS, Hoeks AP, Breteler MM, Witteman JC. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation. 2006;113:657–63.CrossRefPubMed Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, Asmar R, Reneman RS, Hoeks AP, Breteler MM, Witteman JC. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation. 2006;113:657–63.CrossRefPubMed
3.
Zurück zum Zitat Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P, Laurent S. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitude study. Hypertension. 2002;39:10–5.CrossRefPubMed Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P, Laurent S. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitude study. Hypertension. 2002;39:10–5.CrossRefPubMed
4.
Zurück zum Zitat Blacher J, Asmar R, Djane S, London GM, Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension. 1999;33:1111–7.CrossRefPubMed Blacher J, Asmar R, Djane S, London GM, Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension. 1999;33:1111–7.CrossRefPubMed
5.
Zurück zum Zitat Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A. Aortic stiffenss is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236–41.CrossRefPubMed Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A. Aortic stiffenss is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236–41.CrossRefPubMed
6.
Zurück zum Zitat Shokawa T, Imazu M, Yamamoto H, Toyofuku M, Tasaki N, Okimoto T, Yamane K, Kohno N. Pulse wave velocity predicts cardiovascular mortality: findings from the Hawaii-Los Angels-Hiroshima study. Circ J. 2005;69:259–64.CrossRefPubMed Shokawa T, Imazu M, Yamamoto H, Toyofuku M, Tasaki N, Okimoto T, Yamane K, Kohno N. Pulse wave velocity predicts cardiovascular mortality: findings from the Hawaii-Los Angels-Hiroshima study. Circ J. 2005;69:259–64.CrossRefPubMed
7.
Zurück zum Zitat Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness. J Am Coll Cardiol. 2010;55:1318–27.CrossRefPubMed Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness. J Am Coll Cardiol. 2010;55:1318–27.CrossRefPubMed
8.
Zurück zum Zitat Alzamora MT, Forés R, Pera G, Torán P, Heras A, Sorribes M, Baena-Diez JM, Urrea M, Alegre J, Viozquez M, Vela C. Ankle-brachial index and the incidence of cardiovascular events in the Mediterranean low cardiovascular risk population ARTPER cohort. BMC Cardiovasc Disord. 2013;13:119.CrossRefPubMedPubMedCentral Alzamora MT, Forés R, Pera G, Torán P, Heras A, Sorribes M, Baena-Diez JM, Urrea M, Alegre J, Viozquez M, Vela C. Ankle-brachial index and the incidence of cardiovascular events in the Mediterranean low cardiovascular risk population ARTPER cohort. BMC Cardiovasc Disord. 2013;13:119.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Komine H, Asai Y, Yokoi T, Yoshizawa M. Non-invasive assessment of arterial stiffness using oscillometric blood pressure measurement. Biomed Eng Online. 2012;11:6.CrossRefPubMedPubMedCentral Komine H, Asai Y, Yokoi T, Yoshizawa M. Non-invasive assessment of arterial stiffness using oscillometric blood pressure measurement. Biomed Eng Online. 2012;11:6.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Saito Y, Himeno R, Takagi S, LIANG F. Vascular viscoelasticity evaluation device, vascular viscoelasticity method, and program. patent-pending: US20160051151A1. Saito Y, Himeno R, Takagi S, LIANG F. Vascular viscoelasticity evaluation device, vascular viscoelasticity method, and program. patent-pending: US20160051151A1.
11.
Zurück zum Zitat Sueta D, Yamamoto E, Tanaka T, Hirata Y, Sakamoto K, Tsujita K, Kojima S, Nishiyama K, Kaikita K, Hokimoto S, Jinnouchi H, Ogawa H. The accuracy of central blood pressure waveform by novel mathematical transformation of non-invasive measurement. Int J Cardiol. 2015;189:244–6.CrossRefPubMed Sueta D, Yamamoto E, Tanaka T, Hirata Y, Sakamoto K, Tsujita K, Kojima S, Nishiyama K, Kaikita K, Hokimoto S, Jinnouchi H, Ogawa H. The accuracy of central blood pressure waveform by novel mathematical transformation of non-invasive measurement. Int J Cardiol. 2015;189:244–6.CrossRefPubMed
12.
Zurück zum Zitat Sueta D, Yamamoto E, Tanaka T, Hirata Y, Sakamoto K, Tsujita K, Kojima S, Nishiyama K, Kaikita K, Hokimoto S, Jinnouchi H, Ogawa H. Association of estimated central blood pressure measured non- invasively with pulse wave velocity in patients with coronary artery disease. IJC Heart Vasculature. 2015;8:52–4.CrossRef Sueta D, Yamamoto E, Tanaka T, Hirata Y, Sakamoto K, Tsujita K, Kojima S, Nishiyama K, Kaikita K, Hokimoto S, Jinnouchi H, Ogawa H. Association of estimated central blood pressure measured non- invasively with pulse wave velocity in patients with coronary artery disease. IJC Heart Vasculature. 2015;8:52–4.CrossRef
13.
Zurück zum Zitat Patient Survey 2014. Ministry of Health, Labour and Welfare, Japan. http://www.mhlw.go.jp/toukei/itiran/eiyaku.html Accessed 14 Apr 2016 Patient Survey 2014. Ministry of Health, Labour and Welfare, Japan. http://​www.​mhlw.​go.​jp/​toukei/​itiran/​eiyaku.​html Accessed 14 Apr 2016
Metadaten
Titel
Association between novel arterial stiffness indices and risk factors of cardiovascular disease
verfasst von
Masaki Okamoto
Fumiaki Nakamura
Terunaga Musha
Yasuki Kobayashi
Publikationsdatum
01.12.2016
Verlag
BioMed Central
Erschienen in
BMC Cardiovascular Disorders / Ausgabe 1/2016
Elektronische ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-016-0389-x

Weitere Artikel der Ausgabe 1/2016

BMC Cardiovascular Disorders 1/2016 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.